The initiation of coverage by Benchmark with a Buy rating and a specific price target of $10 suggests a positive outlook for Cantaloupe's stock. This kind of analyst coverage often leads to increased investor interest and can positively impact the stock price in the short term, especially when the target price suggests a significant upside.